États-Unis · Plateformes & données · MarketBeat

What Lazard (LAZ) Said on Its Q3 Earnings Call

Publié par MarketBeat · États-Unis il y a 2 h

Lazard (NYSE:LAZ) reported that adjusted net revenue rose 11% year over year in the third quarter of 2026, supported by record quarterly financial advisory revenue and continued…

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

What Lazard (LAZ) Said on Its Q3 Earnings Call

À lire aussi

Treasury yields see extreme plunge. Why investors are ducking for cover.

Merck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fall

XRP ETFs pull in $1.8 billion since launch. Is a rally next?

When will mortgage rates go down? A slight drop this week teases would-be borrowers

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

MRNA Stock Plunges 18% After Leaked Melanoma Vaccine Data Misses High Hopes

What Lazard (LAZ) Said on Its Q3 Earnings Call

Partager

À lire aussi

Treasury yields see extreme plunge. Why investors are ducking for cover.

Merck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fall

XRP ETFs pull in $1.8 billion since launch. Is a rally next?

When will mortgage rates go down? A slight drop this week teases would-be borrowers

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

MRNA Stock Plunges 18% After Leaked Melanoma Vaccine Data Misses High Hopes